Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy — Stella

Home/Diffuse Large B Cell Lymphoma/Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

View on ClinicalTrials.gov

Recruiting

Back to Diffuse Large B Cell Lymphoma trials

Long-term Follow-up Study of Lentiviral-based Gene-edited Immune Cell Therapy

Trial locations(5 sites)

Taiwan

Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan

National Taiwan University Hospital, Taipei, Taiwan

Taipei Veterans General Hospital, Taipei, Taiwan

Chi Mei Medical Center, Tainan

Taipei Medical University - Taipei Medical University Hospital, Taipei

Key details

Sponsor

Pell Bio-Med Technology Co., Ltd.

Enrollment target

~49 participants

Started

December 2022

Primary completion

December 2036

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.